| expression in oral potentially malignant lesions might indicate a progressive deregulation of expression paralleling oncogenesis | oral |
| Survivin expression in astrocytic tumors varies with histologic malignancy and may play an important role in the oncogenesis and progression of astrocytic tumors | None |
| survivin is upregulated by oncogenic c-H-Ras in tumor cells | None |
| These results support the notion that the upregulation of survivin in cancer cells is reflective of an oncogenic event. | None |
| These results suggest that Epstein-Barr virus nuclear antigen 1 can contribute to the oncogenic process by up-regulating the apoptosis suppressor protein survivin. | None |
| BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. | None |
| MYCN and survivin cooperatively contribute to malignant transformation of fibroblasts. | None |
| Proto-oncogene survivin was increased in individuals prior to onset of symptoms of rheumatoid arthritis and was correlated to cytokines suggesting its role at pre-clinical stages of the disease | None |
| Association between functional variants in BIRC5/survivin gene 3 untranslated region and mRNA expression in lymphoblastoid cell lines. | None |
| The mRNA and protein expression level of SOX2 and Survivin was significantly higher in salivary adenoid cystic carcinoma tissues than in paracancerous normal salivary gland tissues, indicating that both of the two are tissue-specific and may become salivary adenoid cystic carcinoma oncogenes. | None |
| The protooncogene survivin was identified as a functional target of miR3305p, and this was validated using a luciferase reporter assay. | None |